CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | Myles Edward H Chief Financial Officer | Grant or award | +24,150 | 24,150 | ||
| 2021-02-01 | Myles Edward H Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +80,500 | 346,301 | ||
| 2021-02-01 | Kingsley Stuart A President and CEO | Grant or award | +42,000 | 42,000 | ||
| 2021-02-01 | Kingsley Stuart A President and CEO | Grant or award · Stock Option (Right to Buy) | +140,000 | 590,000 | ||
| 2021-01-27 | Carven Gregory John Head of Research | Sale | −5,400 | $55.87 | $302K | 46,434 |
| 2021-01-27 | Carven Gregory John Head of Research | Sale | −12,139 | $56.72 | $689K | 34,295 |
| 2021-01-27 | Carven Gregory John Head of Research | Sale | −1,561 | $57.79 | $90K | 32,734 |
| 2021-01-27 | Carven Gregory John Head of Research | Exercise or conversion | +6,619 | $15.11 | $100K | 82,734 |
| 2021-01-27 | Carven Gregory John Head of Research | Sale | −5,400 | $55.87 | $302K | 40,560 |
| 2021-01-27 | Carven Gregory John Head of Research | Sale | −12,139 | $56.72 | $689K | 28,421 |
| 2021-01-27 | Carven Gregory John Head of Research | Sale | −1,561 | $57.79 | $90K | 26,860 |
| 2021-01-27 | Carven Gregory John Head of Research | Exercise or conversion · Stock Option (Right to Buy) | −6,619 | 16,316 | ||
| 2021-01-26 | Carven Gregory John Head of Research | Sale | −2,543 | $60.65 | $154K | 52,898 |
| 2021-01-26 | Carven Gregory John Head of Research | Sale | −1,064 | $61.52 | $65K | 51,834 |
| 2021-01-26 | Gilman Michael Director | Exercise or conversion | +2,188 | $5.77 | $13K | 46,147 |
| 2021-01-26 | Gilman Michael Director | Exercise or conversion | +1,313 | $5.77 | $8K | 47,460 |
| 2021-01-26 | Gilman Michael Director | Sale | −483 | $57.99 | $28K | 46,977 |
| 2021-01-26 | Gilman Michael Director | Sale | −1,500 | $59.02 | $89K | 45,477 |
| 2021-01-26 | Gilman Michael Director | Sale | −1,518 | $59.90 | $91K | 43,959 |
| 2021-01-26 | Gilman Michael Director | Exercise or conversion · Stock Option (Right to Buy) | −2,188 | 1,314 |
Page 25 of 33 · 642 trades